PERMIT study: a global pooled analysis study of the effectiveness and tolerability of perampanel in routine clinical practice

V Villanueva; W D'Souza; H Goji; DW Kim; C Liguori; R McMurray; I Najm; E Santamarina; BJ Steinhoff; P Vlasov; T Wu; Eugen Trinka

doi:10.1007/s00415-021-10751-y

PERMIT study: a global pooled analysis study of the effectiveness and tolerability of perampanel in routine clinical practice

V Villanueva, W D'Souza, H Goji, DW Kim, C Liguori, R McMurray, I Najm, E Santamarina, BJ Steinhoff, P Vlasov, T Wu, Eugen Trinka (Last author)

Research output: Contribution to journal › Original Article › peer-review

44 Citations (Web of Science)

Original language	English
Journal	JOURNAL OF NEUROLOGY
DOIs	https://doi.org/10.1007/s00415-021-10751-y
Publication status	Published - 2021

Keywords

ADD-ON THERAPY
AMPA-RECEPTOR ANTAGONIST
RANDOMIZED PHASE-III
ADJUNCTIVE PERAMPANEL
REFRACTORY EPILEPSIES
STATUS EPILEPTICUS
ADVERSE EVENTS
EFFICACY
SEIZURES
LEVETIRACETAM

Access to Document

10.1007/s00415-021-10751-y

Cite this

Villanueva, V., D'Souza, W., Goji, H., Kim, DW., Liguori, C., McMurray, R., Najm, I., Santamarina, E., Steinhoff, BJ., Vlasov, P., Wu, T., & Trinka, E. (2021). PERMIT study: a global pooled analysis study of the effectiveness and tolerability of perampanel in routine clinical practice. JOURNAL OF NEUROLOGY https://doi.org/10.1007/s00415-021-10751-y

Villanueva, V ; D'Souza, W ; Goji, H et al. / PERMIT study: a global pooled analysis study of the effectiveness and tolerability of perampanel in routine clinical practice. In: JOURNAL OF NEUROLOGY 2021.

@article{52affe2b42ef4e02a2639f8d2f252fe4,

title = "PERMIT study: a global pooled analysis study of the effectiveness and tolerability of perampanel in routine clinical practice",

keywords = "ADD-ON THERAPY, AMPA-RECEPTOR ANTAGONIST, RANDOMIZED PHASE-III, ADJUNCTIVE PERAMPANEL, REFRACTORY EPILEPSIES, STATUS EPILEPTICUS, ADVERSE EVENTS, EFFICACY, SEIZURES, LEVETIRACETAM",

author = "V Villanueva and W D'Souza and H Goji and DW Kim and C Liguori and R McMurray and I Najm and E Santamarina and BJ Steinhoff and P Vlasov and T Wu and Eugen Trinka",

note = "Trinka: Department of Neurology, Christian-Doppler University Hospital, Paracelsus Medical University, Affiliated EpiCARE Partner, Centre for Cognitive Neuroscience, Salzburg, AustriaNeuroscience Institute, Christian Doppler University Hospital, Paracelsus Medical University, Salzburg, Austria",

year = "2021",

doi = "10.1007/s00415-021-10751-y",

language = "English",

journal = "JOURNAL OF NEUROLOGY ",

issn = "0340-5354",

publisher = "Springer Nature",

}

Villanueva, V, D'Souza, W, Goji, H, Kim, DW, Liguori, C, McMurray, R, Najm, I, Santamarina, E, Steinhoff, BJ, Vlasov, P, Wu, T & Trinka, E 2021, 'PERMIT study: a global pooled analysis study of the effectiveness and tolerability of perampanel in routine clinical practice', JOURNAL OF NEUROLOGY https://doi.org/10.1007/s00415-021-10751-y

PERMIT study: a global pooled analysis study of the effectiveness and tolerability of perampanel in routine clinical practice. / Villanueva, V; D'Souza, W; Goji, H et al.
In: JOURNAL OF NEUROLOGY , 2021.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - PERMIT study: a global pooled analysis study of the effectiveness and tolerability of perampanel in routine clinical practice

AU - Villanueva, V

AU - D'Souza, W

AU - Goji, H

AU - Kim, DW

AU - Liguori, C

AU - McMurray, R

AU - Najm, I

AU - Santamarina, E

AU - Steinhoff, BJ

AU - Vlasov, P

AU - Wu, T

AU - Trinka, Eugen

N1 - Trinka: Department of Neurology, Christian-Doppler University Hospital, Paracelsus Medical University, Affiliated EpiCARE Partner, Centre for Cognitive Neuroscience, Salzburg, AustriaNeuroscience Institute, Christian Doppler University Hospital, Paracelsus Medical University, Salzburg, Austria

PY - 2021

Y1 - 2021

KW - ADD-ON THERAPY

KW - AMPA-RECEPTOR ANTAGONIST

KW - RANDOMIZED PHASE-III

KW - ADJUNCTIVE PERAMPANEL

KW - REFRACTORY EPILEPSIES

KW - STATUS EPILEPTICUS

KW - ADVERSE EVENTS

KW - EFFICACY

KW - SEIZURES

KW - LEVETIRACETAM

U2 - 10.1007/s00415-021-10751-y

DO - 10.1007/s00415-021-10751-y

M3 - Original Article

C2 - 34427754

SN - 0340-5354

JO - JOURNAL OF NEUROLOGY

JF - JOURNAL OF NEUROLOGY

ER -

Villanueva V, D'Souza W, Goji H, Kim DW, Liguori C, McMurray R et al. PERMIT study: a global pooled analysis study of the effectiveness and tolerability of perampanel in routine clinical practice. JOURNAL OF NEUROLOGY . 2021. doi: 10.1007/s00415-021-10751-y